PROLONGED PERPHENAZINE THERAPY AND THYROID FUNCTION
Abstract
The findings in this survey do not support those reported by Cranswick, et al. The slight deviations from normal values in 3 of 25 patients (1 below normal and 2 above) are clinically and statistically insignificant. On the basis of the PBI determinations in these 25 patients on longterm perphenazine therapy, it may be concluded that this phenothiazine has no direct or indirect pathological influence on the thyroid gland.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).